Palisade Bio, Inc. (PALI) NASDAQ
2.08
-0.09(-4.15%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
2.08
-0.09(-4.15%)
Currency In USD
| Market Cap | 130.82M |
| Enterprise Value | -2.49M |
| P/E Ratio | -6.9 |
| PEG Ratio | -0.03 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 0.89 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -11.73 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.12 |
| Return On Equity | -0.48 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -3,000 |
| EBITDA | -18.06M |
| Net Income | -16.78M |
| Diluted EPS | -0.3 |
| Total Cash | 133.39M |
| Total Cash/Share | 2.4 |
| Total Debt | 71,000 |
| Total Debt/Equity | 0 |
| Current Ratio | 28.95 |
| Book Value Per Share | 2.32 |
| 52-Week Change | 182.8 |
| 52-Week High | 2.86 |
| 52-Week Low | 0.53 |
| Moving Average 50 Days | 1.93 |
| Moving Average 200 Days | 1.58 |
| Average Volume | 4.02M |
| Shares Outstanding | 165.89M |
| % Held by Institutions | 1,818 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:15 |
| Last Split Date | April 08, 2024 |